Neoadjuvant, adjuvant and palliative chemotherapy of penile cancer [Neoadjuvante, adjuvante und palliative Chemotherapie des Peniskarzinoms]

被引：0

作者：

Protzel C. ^{[1
]}

Seitz A.K. ^{[2
]}

Hakenberg O.W. ^{[1
]}

Retz M. ^{[2
]}

机构：

[1] Klinik und Poliklinik für Urologie, Universitätsmedizin Rostock, E. Heydemannstraße 6

[2] Klinikum Rechts der Isar, Technischen Universität München, München

来源：

Der Urologe | 2013年 / 52卷 / 11期

关键词：

Best supportive care strategie; Lymph node metastases; Multimodal therapy concept; Salvage lympadenectomy; Targeted therapy;

D O I：

10.1007/s00120-013-3252-z

中图分类号：

学科分类号：

摘要：

Data on the treatment of advanced penile carcinoma especially for chemotherapy are very limited. Due to the results of recent studies there has been a shift to taxan/cisplatinum based regimens. Initial case reports also showed a response to targeted therapy especially antibodies against epidermal growth factor receptor (EGFR). Nevertheless, a curative treatment by medicinal approaches alone does not appear to be possible for metastatic penile cancer and can be only cured by multimodal approaches, including neoadjuvant and adjuvant chemotherapy and salvage lymph node dissection. Palliative chemotherapy of advanced penile cancer has to be individually adapted and weighed against best supportive care for the final decision. © 2013 Springer-Verlag Berlin Heidelberg.

引用

页码：1556 / 1563

页数：7

共 50 条

[31] Is there an indication for adjuvant or neoadjuvant systemic chemotherapy in bladder cancer? [Gibt es eine indikation für eine adjuvante oder neoadjuvante systemtherapie beim blasenkarzinom?]
Suttmann H.
Retz M.
Gschwend J.E.
Stöckle M.
Der Urologe, 2007, 46 (10): : 1379 - 1384
[32] Multimodale Therapie des ÖsophaguskarzinomsNeoadjuvante Chemotherapie vs. neoadjuvante RadiochemotherapieMultimodal therapy of esophageal cancerNeoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy
Jens Höppner
Der Onkologe, 2016, 22 (7): : 509 - 510
[33] Red cell differential width (RDW) as a predictor of survival outcomes with palliative and adjuvant chemotherapy for metastatic penile cancer
Patel, Reena
English, Louise
Liu, Wing K.
Tree, Alison C.
Ayres, Benjamin
Watkin, Nick
Pickering, Lisa M.
Afshar, Mehran
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2020, 52 (12) : 2301 - 2306
[34] Red cell differential width (RDW) as a predictor of survival outcomes with palliative and adjuvant chemotherapy for metastatic penile cancer
Reena Patel
Louise English
Wing K. Liu
Alison C. Tree
Benjamin Ayres
Nick Watkin
Lisa M. Pickering
Mehran Afshar
International Urology and Nephrology, 2020, 52 : 2301 - 2306
[35] Neoadjuvante Radiochemotherapie oder Chemotherapie beim lokal fortgeschrittenen Ösophaguskarzinom?Neoadjuvant chemoradiotherapy or chemotherapy for locally advanced esophageal cancer?
B. Babic
H. F. Fuchs
C. J. Bruns
Der Chirurg, 2020, 91 (5): : 379 - 383
[36] Position of adjuvant and palliative chemotherapy in colonic cancer treatment.
Louvet, C
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1998, 22 (3BIS): : S255 - S264
[37] Economic assessment of adjuvant and palliative chemotherapy in colorectal cancer: a review
Selke, B
Lebrun, T
Comte, S
BULLETIN DU CANCER, 2003, 90 (02) : 143 - 149
[38] Effects of postoperative adjuvant chemotherapy and palliative chemotherapy on the gut microbiome in colorectal cancer
Han Shuwen
Yang Xi
Pan Yuefen
Xu Jiamin
Qi Quan
Liao Haihong
Jiang Yizhen
Wu Wei
MICROBIAL PATHOGENESIS, 2020, 149
[39] Primäre und sekundäre Lymphome des Gastrointestinaltraktes: Chemotherapie im primären, adjuvanten und palliativen EinsatzPrimary and secondary lymphomas of the gastrointestinal tract: Cytotoxic Chemotherapy for primary, adjuvant and palliative treatment
R. Greil
Acta chirurgica Austriaca, 1998, 30 (5) : 274 - 281
[40] Results of the radiotherapeutic Treatment of Patients with Pancreatic Cancer in neoadjuvant, adjuvant and palliative Intent
Hero, T.
Ohlmann, S.
Zeller, S.
Uhl, W.
Buehler, H.
Adamietz, I. A.
STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 : S113 - S113

← 1 2 3 4 5 →